Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6ITY

CTX-M-64 sulbactam complex

6ITY の概要
エントリーDOI10.2210/pdb6ity/pdb
分子名称Beta-lactamase, TRANS-ENAMINE INTERMEDIATE OF SULBACTAM, ACRYLIC ACID, ... (4 entities in total)
機能のキーワードbeta-lactamase inhibitor complex, hydrolase
由来する生物種Escherichia coli
タンパク質・核酸の鎖数2
化学式量合計58892.44
構造登録者
Cheng, Q.,Chen, S. (登録日: 2018-11-26, 公開日: 2019-10-30, 最終更新日: 2024-03-27)
主引用文献Cheng, Q.,Xu, C.,Chai, J.,Zhang, R.,Wai Chi Chan, E.,Chen, S.
Structural Insight into the Mechanism of Inhibitor Resistance in CTX-M-199, a CTX-M-64 Variant Carrying the S130T Substitution.
Acs Infect Dis., 6:577-587, 2020
Cited by
PubMed Abstract: The smart design of β-lactamase inhibitors allowed us to combat extended-spectrum β-lactamase (ESBL)-producing organisms for many years without developing resistance to these inhibitors. However, novel resistant variants have emerged recently, and notable examples are the CTX-M-190 and CTX-M-199 variants, which carried a ST amino acid substitution and exhibited resistance to inhibitors such as sulbactam and tazobactam. Using mass spectrometric and crystallographic approaches, this study depicted the mechanisms of inhibitor resistance. Our data showed that CTX-M-64 (ST) did not cause any conformational change or exert any effect on its ability to hydrolyze β-lactam substrates. However, binding of sulbactam, but not clavulanic acid, to the active site of CTX-M-64 (ST) led to the conformational changes in such active site, which comprised the key residues involved in substrate catalysis, namely, Thr, Lys, Lys, Asn, and Asn. This conformational change weakened the binding of the sulbactam -enamine intermediate (TSL) to the active site and rendered the formation of the inhibitor-enzyme complex, which features a covalent acrylic acid (AKR)-T bond, inefficient, thereby resulting in inhibitor resistance in CTX-M-64 (ST). Understanding the mechanisms of inhibitor resistance provided structural insight for the future development of new inhibitors against inhibitor-resistant β-lactamases.
PubMed: 31709791
DOI: 10.1021/acsinfecdis.9b00345
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.14 Å)
構造検証レポート
Validation report summary of 6ity
検証レポート(詳細版)ダウンロードをダウンロード

229380

件を2024-12-25に公開中

PDB statisticsPDBj update infoContact PDBjnumon